Fig. 3From: Investigating PSMA differential expression in canine uroepithelial carcinomas to aid disease-based stratification and guide therapeutic selectionDose-response line graphs of canine uroepithelial carcinoma cell lines to each urothelial directed chemotherapeutic agent. In each of four panels of different chemotherapeutic agents, 5 canine iUC (left) and 4 canine PCA (right) cell lines were incubated with varying concentrations of drug for 72 hours, then processed using Sulforhodamine B assay. Dot size indicates SEMBack to article page